Moitra M, Santomauro D, Collins PY, Vos T, Whiteford H, Saxena S, et al
Many patients benefit, but response varies
In the United States, some of the medications have been approved as treatments for other conditions, including sleep apnea and reducing the risk of heart problems and kidney disease progression
If you're looking for a practitioner who views the body as an integrated system and can craft a strategy uniquely tailored to your physiology, an FMU graduate is an ideal resource
October 1, 2025: Most Ozempic Users Stop Taking It Within First Year of Starting, Study Finds A new study has found that most people who take Ozempic discontinue treatment within 1 year
Compliance was tracked meticulously